![]() |
|
|
Vol. 293, Issue 1, 128-135, April 2000
Department of Pharmacology, Tokushima University School of
Dentistry, Tokushima, Japan
The perfusion of rat small intestinal lumen with epinephrine (0.1 mM)
resulted in a significant increase in the amount of benzylpenicillin
(BP) transported from the mucosal to the serosal side. In this study,
the perfusion of the lumen with phenylephrine, clonidine, dobutamine,
or salbutamol had no effect on BP transport. However, the combinations
of phenylephrine and isoproterenol, clonidine and isoproterenol, and
phenylephrine and salbutamol increased the BP transport to a similar
extent as that observed with epinephrine alone. Tolazolin or
propranolol inhibited the epinephrine-induced increase in BP transport.
An increase in the intracellular concentration of cAMP in conjunction
with specific activation of either
1- or
2-adrenoceptors induced an increase in BP transport
similar to that observed in response to epinephrine alone.
Staurosporine or
N-[2-(methylamino)ethyl]-5-isoquinolinesulfonamide abolished the epinephrine-induced increase in BP transport. Peptides or
either zwitterionic or anionic cephalosporins also blocked the effect
of epinephrine on BP transport. The extent of BP uptake into brush
border or basolateral membrane vesicles prepared from epinephrine-perfused intestinal loops was markedly greater than that
into vesicles prepared from control loops. The perfusion of intestinal
lumen with carbonyl cyanide p-trifluoromethoxy
phenylhydrazone, amiloride, or ouabain inhibited epinephrine-induced BP
transport. These results indicate that the interaction of epinephrine
with both
2-adrenoceptors and either
1-
or
2-adrenoceptors markedly stimulates the BP transport,
an effect likely mediated by the enhancement of the function in the
brush border membrane of intestinal epithelial cells coupled with the
generation of an H+ gradient.
This article has been cited by other articles:
![]() |
R. K. Bhardwaj, D. Herrera-Ruiz, P. J. Sinko, O. S. Gudmundsson, and G. Knipp Delineation of Human Peptide Transporter 1 (hPepT1)-Mediated Uptake and Transport of Substrates with Varying Transporter Affinities Utilizing Stably Transfected hPepT1/Madin-Darby Canine Kidney Clones and Caco-2 Cells J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1093 - 1100. [Abstract] [Full Text] [PDF] |
||||